Sarclisa (isatuximab)

**Product type:** Human Prescription Drug

**Active ingredient:** ISATUXIMAB

**Strength:** 500 mg/25mL

**Dosage form:** Injection, Solution, Concentrate

**Route:** Intravenous

**Labeler:** Sanofi-Aventis U.S. LLC

**Marketing category:** BLA (BLA761113)

**Pharmacologic class:** Antibodies, Monoclonal [CS], CD38-directed Antibody Interactions [MoA], CD38-directed Cytolytic Antibody [EPC]